http://www.prlog.org/10130213-new-book-on-alcoholism-applauded-by-national-anxiety-foundations-dr-stephen-cox.html

http://www.prlog.org/10130213-new-book-on-alcoholism-applauded-by-national-anxiety-foundations-dr-stephen-cox.html

I'm very impressed with the second book by Ameisen relative to how the
medication, baclofen, has helped him and others (case studies) who, after
suffered from alcoholism for their entire adult life, manage to completely
recover from their cravings and need for alcohol when taking baclofen. 
The author also provides many examples of animals studies that have shown
how baclofen has cured rats addiction to cocaine as well as other drugs. 
He discusses his ongoing urgent efforts to get researchers in the field of
addiction to conduct large, randomized studies with humans on the impact
of baclofen on various types of addiction and, initially, was puzzled by
the persistent lack of interest of these researchers.  Later he comes
across a possible explanation--that baclofen is now a generic drug so
pharmaceutical companies no longer have any financial gain in funding
large studies of the effectiveness of this particular drug.  Of course, to
the contrary, these companies are very willing and able to fund large,
randomized studies of the use of drugs still under patent to assist with
the alcohol addition.  A sobering and unfortunate reality.

The URL for this book also contains comments from the public on how our
society is not quite "ready" for this type of answer to curing addictions,
 with which I concur.  Fascination book I highly recommend.

The first URL in this email takes you to another book recommending a
different medication to "cure" alcoholism but I have not read it so can't
comment on the quality of it's empirical support.

Joan
[email protected]





> Post something!
>
> Michael Sylvester,PhD
> Tipster in relapse
> Daytona Beach,Florida
> ---
> To make changes to your subscription contact:
>
> Bill Southerly ([email protected])





---
To make changes to your subscription contact:

Bill Southerly ([email protected])

Reply via email to